학술논문
'학술논문'
에서 검색결과 414건 | 목록
1~10
Academic Journal
Makhlin I; Hospital of the University of Pennsylvania, Philadelphia, PA.; Fallowfield L; University of Sussex, Brighton, United Kingdom.; Henry NL; University of Michigan, Ann Arbor, MI.; Burstein HJ; Dana Farber Cancer Institute, Boston, MA.; Somerfield MR; American Society of Clinical Oncology, Alexandria, VA.; DeMichele A; University of Pennsylvania, Philadelphia, PA.
Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101758685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2688-1535 (Electronic) Linking ISSN: 26881527 NLM ISO Abbreviation: JCO Oncol Pract Subsets: MEDLINE
Academic Journal
Wong JS; Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Brigham and Women's Hospital, Boston, Massachusetts.; Uno H; Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Tramontano AC; Dana-Farber Cancer Institute, Boston, Massachusetts.; Fisher L; Dana-Farber Cancer Institute, Boston, Massachusetts.; Pellegrini CV; Dana-Farber Cancer Institute, Boston, Massachusetts.; Abel GA; Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Burstein HJ; Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Brigham and Women's Hospital, Boston, Massachusetts.; Chun YS; Harvard Medical School, Boston, Massachusetts.; Brigham and Women's Hospital, Boston, Massachusetts.; King TA; Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Brigham and Women's Hospital, Boston, Massachusetts.; Schrag D; Memorial Sloan Kettering Cancer Center, New York, New York.; Winer E; Yale Cancer Center, New Haven, Connecticut.; Bellon JR; Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Brigham and Women's Hospital, Boston, Massachusetts.; Cheney MD; Maine Medical Center, Portland, Maine.; Hardenbergh P; Vail Health, Vail, Colorado.; Ho A; Duke University Medical Center, Durham, North Carolina.; Horst KC; Stanford University School of Medicine, Stanford, California.; Kim JN; Fred Hutchinson Cancer Center/UW Medicine, Seattle, Washington.; Leonard KL; Warren Alpert Medical School of Brown University, Providence, Rhode Island.; Rhode Island Hospital, Providence.; Moran MS; Yale Cancer Center, New Haven, Connecticut.; Park CC; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California.; Recht A; Harvard Medical School, Boston, Massachusetts.; Beth Israel Deaconess Medical Center, Boston, Massachusetts.; Soto DE; Massachusetts General Hospital, Boston.; Shiloh RY; Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Brigham and Women's Hospital, Boston, Massachusetts.; Stinson SF; Johns Hopkins School of Medicine, Baltimore, Maryland.; Snyder KM; Northern Light Health, Brewer, Maine.; Taghian AG; Harvard Medical School, Boston, Massachusetts.; Massachusetts General Hospital, Boston.; Warren LE; Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Brigham and Women's Hospital, Boston, Massachusetts.; Wright JL; Johns Hopkins School of Medicine, Baltimore, Maryland.; Punglia RS; Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Brigham and Women's Hospital, Boston, Massachusetts.
Publisher: American Medical Association Country of Publication: United States NLM ID: 101652861 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2374-2445 (Electronic) Linking ISSN: 23742437 NLM ISO Abbreviation: JAMA Oncol Subsets: MEDLINE
Academic Journal
Valenza C; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Trapani D; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Loibl S; Center for Hematology and Oncology Bethanien, Frankfurt, Germany.; Chia SKL; BC Cancer Agency, Vancouver, BC, Canada.; Burstein HJ; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA.; Curigliano G; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
Academic Journal
Boscolo Bielo L; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Trapani D; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Nicolò E; Department of Medicine, Division of Hematology-Oncology, Weill Cornell Medicine, New York, NY, USA.; Valenza C; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Guidi L; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Belli C; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy.; Kotteas E; Oncology Unit, Sotiria General Hospital, 3rd Dept of Internal Medicine, Athens School of Medicine, Greece.; Marra A; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy.; Prat A; Department of Medical Oncology and Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Faculty of Medicine and Health Sciences, University of Barcelona, Spain.; Fusco N; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy; Division of Pathology, IEO, European Institute of Oncology IRCCS, Milan, Italy.; Criscitiello C; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Burstein HJ; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.; Curigliano G; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy. Electronic address: giuseppe.curigliano@ieo.it.
Publisher: Elsevier Country of Publication: Netherlands NLM ID: 7502030 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1967 (Electronic) Linking ISSN: 03057372 NLM ISO Abbreviation: Cancer Treat Rev Subsets: MEDLINE
Academic Journal
Gradishar WJ; Robert H . Lurie Comprehensive Cancer Center of Northwestern University.; Moran MS; Yale Cancer Center/Smilow Cancer Hospital.; Abraham J; Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute.; Abramson V; Vanderbilt-Ingram Cancer Center.; Aft R; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine.; Agnese D; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute.; Allison KH; Stanford Cancer Institute.; Anderson B; University of Wisconsin Carbone Cancer Center.; Bailey J; University of Michigan Rogel Cancer Center.; Burstein HJ; Dana-Farber/Brigham and Women's Cancer Center.; Chen N; The UChicago Medicine Comprehensive Cancer Center.; Chew H; UC Davis Comprehensive Cancer Center.; Dang C; Memorial Sloan Kettering Cancer Center.; Elias AD; University of Colorado Cancer Center.; Giordano SH; The University of Texas MD Anderson Cancer Center.; Goetz MP; Mayo Clinic Comprehensive Cancer Center.; Jankowitz RC; Abramson Cancer Center at the University of Pennsylvania.; Javid SH; Fred Hutchinson Cancer Center.; Krishnamurthy J; Fred & Pamela Buffett Cancer Center.; Leitch AM; UT Southwestern Simmons Comprehensive Cancer Center.; Lyons J; Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute.; McCloskey S; UCLA Jonsson Comprehensive Cancer Center.; McShane M; Fox Chase Cancer Center.; Mortimer J; City of Hope National Medical Center.; Patel SA; Fox Chase Cancer Center.; Rosenberger LH; Duke Cancer Institute.; Rugo HS; UCSF Helen Diller Family Comprehensive Cancer Center.; Santa-Maria C; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.; Schneider BP; Indiana University Melvin and Bren Simon Comprehensive Cancer Center.; Smith ML; Research Advocacy Network.; Soliman H; Moffitt Cancer Center.; Stringer-Reasor EM; O'Neal Comprehensive Cancer Center at UAB.; Telli ML; Stanford Cancer Institute.; Wei M; Huntsman Cancer Institute at the University of Utah.; Wisinski KB; University of Wisconsin Carbone Cancer Center.; Yeung KT; UC San Diego Moores Cancer Center.; Young JS; Roswell Park Comprehensive Cancer Center.; Schonfeld R; National Comprehensive Cancer Network.; Kumar R; National Comprehensive Cancer Network.
Publisher: Harborside Press Country of Publication: United States NLM ID: 101162515 Publication Model: Print Cited Medium: Internet ISSN: 1540-1413 (Electronic) Linking ISSN: 15401405 NLM ISO Abbreviation: J Natl Compr Canc Netw Subsets: MEDLINE
Academic Journal
Tarantino P; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Tayob N; Harvard Medical School, Boston, MA.; Division of Data Science, Dana-Farber Cancer Institute, Boston, MA.; Villacampa G; SOLTI Breast Cancer Research Group, Barcelona, Spain.; Oncology Data Science Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Dang C; Memorial Sloan Kettering Cancer Center, New York, NY.; Yardley DA; Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN.; Isakoff SJ; Harvard Medical School, Boston, MA.; Massachusetts General Hospital, Boston, MA.; Valero V; MD Anderson Cancer Center, Houston, TX.; Faggen M; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Mulvey T; Harvard Medical School, Boston, MA.; Massachusetts General Hospital, Boston, MA.; Bose R; Washington University School of Medicine, St Louis, MO.; Weckstein D; New Hampshire Oncology Hematology, Manchester, NH.; Wolff AC; Johns Hopkins Sidney Kimmel Cancer Center, Washington, DC.; Reeder-Hayes K; University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC.; Rugo HS; University of California, San Francisco, CA.; Ramaswamy B; Ohio State University Comprehensive Cancer Center, Columbus, OH.; Zuckerman D; St Luke's Mountain States Tumor Institute, Boise, ID.; Hart L; Wake Forest Baptist Health, Winston-Salem, NC.; Gadi VK; University of Illinois Cancer Center, Chicago, IL.; Constantine M; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Cheng K; North Shore-LIJ Cancer Institute, Lake Success, NY.; Garrett AM; Northern Light Cancer Care, Brewer, ME.; Marcom PK; Duke University School of Medicine, Durham, NC.; Albain K; Loyola University Medical Center, Maywood, IL.; DeFusco P; Hartford Healthcare Cancer Institute, Hartford, CT.; Tung N; Harvard Medical School, Boston, MA.; Beth Israel Deaconess Medical Center, Boston, MA.; Ardman B; Lowell General Hospital, Lowell, MA.; Nanda R; UChicago Medicine, Chicago, IL.; Jankowitz RC; Perelman Center for Advanced Medicine, Philadelphia, PA.; Rimawi M; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX.; Abramson V; Vanderbilt-Ingram Cancer Center, Nashville, TN.; Pohlmann PR; MD Anderson Cancer Center, Houston, TX.; Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC.; Van Poznak C; Rogel Cancer Center, University of Michigan, Ann Arbor, MI.; Forero-Torres A; Kirklin UAB Hematology Oncology, Birmingham, AL.; Liu MC; Natera, Inc, Austin, TX.; Ruddy KJ; Mayo Clinic, Rochester, NY.; Waks AG; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA.; DeMeo M; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Burstein HJ; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA.; Partridge AH; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA.; Dell'Orto P; IEO European Institute of Oncology, IRCCS, Milan, Italy.; Russo L; IEO European Institute of Oncology, IRCCS, Milan, Italy.; Krause E; PathAI, Boston, MA.; Newhouse DJ; NanoString Technologies, Inc, Boston, MA.; Kurt BB; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Mittendorf EA; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA.; Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA.; Schneider B; Indiana University School of Medicine, Indianapolis, IN.; Prat A; SOLTI Breast Cancer Research Group, Barcelona, Spain.; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain.; Winer EP; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA.; Yale Cancer Center, New Haven, CT.; Krop IE; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA.; Yale Cancer Center, New Haven, CT.; Tolaney SM; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA.
Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
Academic Journal
Mayer EL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Ren Y; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA.; Wagle N; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Mahtani R; Department of Medical Oncology, Miami Cancer Institute, Miami, FL.; Ma C; Division of Oncology, Department of Medicine, Washington University School of Medicine, St Louis, MO.; DeMichele A; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.; Cristofanilli M; Department of Medical Oncology, Weill Cornell Medicine, New York, NY.; Meisel J; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA.; Miller KD; Hematology/Oncology Division, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN.; Abdou Y; Department of Medicine, University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC.; Riley EC; Department of Medicine, Brown Cancer Center, University of Louisville Health, Louisville, KY.; Qamar R; Aurora Cancer Care, Milwaukee, WI.; Sharma P; Department of Medical Oncology, University of Kansas Medical Center, Westwood, KS.; Reid S; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN.; Sinclair N; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Faggen M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Block CC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Ko N; Department of Medical Oncology, Boston Medical Center, Boston, MA.; Partridge AH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Chen WY; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; DeMeo M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Attaya V; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Okpoebo A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Alberti J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Liu Y; Pfizer, La Jolla, CA.; Gauthier E; Pfizer, La Jolla, CA.; Burstein HJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Regan MM; Harvard Medical School, Boston, MA.; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA.; Tolaney SM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.
Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
Academic Journal
Burstein HJ; Dana Farber Cancer Institute, Boston, MA.; DeMichele A; University of Pennsylvania, Philadelphia, PA.; Fallowfield L; University of Sussex, Brighton, United Kingdom.; Somerfield MR; American Society of Clinical Oncology, Alexandria, VA.; Henry NL; University of Michigan, Ann Arbor, MI.
Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
Academic Journal
Higgins T; Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Kantor O; Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Harrison B; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Giordano J; Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; McGrath M; Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Burstein HJ; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Division of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Schnitt SJ; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Rahman T; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Vora H; Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA.; Department of Surgery, Loma Linda University School of Medicine, Loma Linda, CA, USA.; Garrido-Castro A; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Division of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Tolaney SM; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Division of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Meric-Bernstam F; Department of Investigational Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; King TA; Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Mittendorf EA; Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA. emittendorf@bwh.harvard.edu.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA. emittendorf@bwh.harvard.edu.; Harvard Medical School, Boston, MA, USA. emittendorf@bwh.harvard.edu.
Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: MEDLINE
Loibl S; GBG Forschungs GmbH, Neu-Isenburg; Centre for Haematology and Oncology, Bethanien, Frankfurt, Germany.; André F; Breast Cancer Unit, Medical Oncology Department, Gustave Roussy, Cancer Campus, Villejuif.; Bachelot T; Department of Medical Oncology, Centre Léon Bérard, Lyon, France.; Barrios CH; Oncology Department, Latin American Cooperative Oncology Group and Oncoclínicas, Porto Alegre, Brazil.; Bergh J; Department of Oncology-Pathology, Bioclinicum, Karolinska Institutet and Breast Cancer Centre, Karolinska Comprehensive Cancer Centre and University Hospital, Stockholm, Sweden.; Burstein HJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA.; Cardoso MJ; Breast Unit, Champalimaud Foundation, Champalimaud Cancer Centre, Lisbon; Faculty of Medicine, Lisbon University, Lisbon, Portugal.; Carey LA; Division of Medical Oncology, The University of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer Center, Chapel Hill, USA.; Dawood S; Department of Oncology, Mediclinic City Hospital, Dubai, UAE.; Del Mastro L; Medical Oncology Clinic, IRCCS Ospedale Policlinico San Martino, Genoa; Department of Internal Medicine and Medical Specialities, School of Medicine, University of Genoa, Genoa, Italy.; Denkert C; Institute of Pathology, Philipps-University Marburg and University Hospital Giessen and Marburg, Marburg.; Fallenberg EM; Department of Diagnostic and Interventional Radiology, School of Medicine & Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany.; Francis PA; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia.; Gamal-Eldin H; Department of Surgical Oncology, National Cancer Institute, Cairo University, Cairo, Egypt.; Gelmon K; Department of Medical Oncology, British Columbia Cancer, Vancouver, Canada.; Geyer CE; Department of Internal Medicine, Hillman Cancer Center, University of Pittsburgh, Pittsburgh, USA.; Gnant M; Comprehensive Cancer Centre, Medical University of Vienna, Vienna, Austria.; Guarneri V; Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova; Oncology 2 Unit, Istituto Oncologico Veneto IOV IRCCS, Padova, Italy.; Gupta S; Department of Medical Oncology, Tata Memorial Centre, Mumbai, India.; Kim SB; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.; Krug D; Department of Radiation Oncology, University Hospital Schleswig-Holstein, Kiel, Germany.; Martin M; Hospital General Universitario Gregorio Maranon, Universidad Complutense, GEICAM, Madrid, Spain.; Meattini I; Department of Radiation Oncology, Azienda Ospedaliero-Universitaria Careggi, Florence; Department of Experimental and Clinical Biomedical Sciences 'M. Serio', University of Florence, Florence, Italy.; Morrow M; Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, USA.; Janni W; Department of Obstetrics and Gynaecology, University of Ulm, Ulm, Germany.; Paluch-Shimon S; Sharett Institute of Oncology Department, Hadassah University Hospital & Faculty of Medicine Hebrew University, Jerusalem, Israel.; Partridge A; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA.; Poortmans P; Department of Radiation Oncology, Iridium Netwerk, Antwerp; Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.; Pusztai L; Yale Cancer Center, Yale School of Medicine, New Haven.; Regan MM; Division of Biostatistics, Dana-Farber Cancer Institute, Harvard Medical School, Boston.; Sparano J; Department of Medicine, Division of Hematology/Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA.; Spanic T; Europa Donna Slovenia, Ljubljana, Slovenia.; Swain S; Medicine Department, Georgetown University Medical Centre and MedStar Health, Washington, USA.; Tjulandin S; N.N. Blokhin National Medical Research Centre of Oncology, Moscow, Russia.; Toi M; Tokyo Metropolitan Cancer and Infectious Disease Center, Komagome Hospital, Bunkyo-ku, Japan.; Trapani D; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA.; Tutt A; Breast Cancer Research Division, The Institute of Cancer Research, London; Comprehensive Cancer Centre, Division of Cancer Studies, Kings College London, London, UK.; Xu B; Department of Medical Oncology, National Cancer Centre/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.; Curigliano G; Early Drug Development for Innovative Therapies Division, Istituto Europeo di Oncologia, IRCCS, Milan; Department of Oncology and Hemato-Oncology, University of Milano, Milan, Italy.; Harbeck N; Breast Centre, Department of Obstetrics & Gynaecology and Comprehensive Cancer Centre Munich, LMU University Hospital, Munich, Germany.
Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[AR] Burstein HJ
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어